Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Project EXCEL will provide community or online exercise programs to rural and remote and under-served cancer survivors, as well as encourage participants to become life-long exercisers. Exercise is an evidence-based self-management strategy that benefits all cancer survivors. However, most cancer survivors who live in remote or rural places don't have adequate opportunities to be involved in exercise programs that are tailored to their needs.
Description: Change in number of participants meeting Guidelines for Physical Activity of 150 minutes per week of moderate intensity exercise, based on accelerometer data from commercially-available activity tracker.
Measure: Physical Activity Minutes Per Week Time: Baseline to one-yearDescription: Change in body mass index (BMI)
Measure: Body Composition Time: Baseline to post 12-week exercise interventionDescription: Change in 6-minute walk test (m) or 2 minute step test (steps) results
Measure: Aerobic Endurance Time: Baseline to post 12-week exercise interventionDescription: Change in hand-grip dynamometry (kg)
Measure: Upper extremity grip strength Time: Baseline to post 12-week exercise interventionDescription: Change in sit-to-stand (number of repetitions in 30 seconds)
Measure: Functional performance test Time: Baseline to post 12-week exercise interventionDescription: Change in active shoulder flexion range of motion (degrees)
Measure: Upper extremity flexibility Time: Baseline to post 12-week exercise interventionDescription: Change in sit-and-reach test (cm)
Measure: Lower extremity flexibility Time: Baseline to post 12-week exercise interventionDescription: Change in one legged stance test (seconds)
Measure: Balance Time: Baseline to post 12-week exercise interventionDescription: Change in fatigue, mood, and QOL, recorded via m-Health app
Measure: Symptom tracking Time: Baseline to one yearDescription: Change in Edmonton Symptom Assessment Scale. - scale is from 0-10, where 0 means the symptom is absent and 10 means the worst possible severity of the symptom is being experienced.
Measure: Cancer related symptoms Time: Baseline to one yearDescription: Change in Godin Leisure Time Exercise Questionnaire
Measure: Subjective reporting of average weekly physical activity Time: Baseline to one yearDescription: Change in EuroQual - 5Dimensions (EQ-5D) tool - first section is a questionniare; last section uses a scale from 0-100, where 0 means the worst health imaginable and 100 means the best health imaginable.
Measure: General Health-related Quality of Life Time: Baseline to one yearDescription: Change in Functional Assessment of Chronic Illness Therapy - Fatigue subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
Measure: Fatigue Time: Baseline to one yearDescription: Change in Functional Assessment of Cancer Therapy - General subscale - scale is from 0-4, where 0 means "not at all" and 4 means "very much".
Measure: General well-being Time: Baseline to one yearDescription: Change in Functional Assessment of Cancer Therapy - Cognitive subscale - scale is from 0-4, where 0 means "never" and 4 means "several times a day" (experiencing symptoms).
Measure: Cognition Time: Baseline to one yearDescription: Change in Exercise Barriers and Facilitators questionnaire
Measure: Barriers and facilitators to exercise participation Time: Baseline to one yearDescription: Adherence to exercise programming (attendance at sessions)
Measure: Exercise adherence Time: Baseline to one yearDescription: RE-AIM: program reach, effectiveness, adoption, implementation and maintenance
Measure: Program implementation and evaluation Time: Baseline to one yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports